Bernstein Maintains Outperform on Insulet, Lowers Price Target to $175
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Bernstein analyst Lee Hambright maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $200 to $175.
Bernstein analyst Lee Hambright maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $200 to $175.